Carregant...
ALK (D5F3) CDx: an immunohistochemistry assay to identify ALK-positive NSCLC patients
Screening for anaplastic lymphoma kinase (ALK) rearrangements is a very important process in treatment decision making for advanced non-small-cell lung cancer (NSCLC). Although fluorescent in situ hybridization (FISH) is considered the universally accepted reference standard, it is associated with t...
Guardat en:
| Publicat a: | Pharmgenomics Pers Med |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6147206/ https://ncbi.nlm.nih.gov/pubmed/30271189 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S156672 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|